규제 업데이트2026년 9월 22일•1분 읽기

FDA Approves ANDA088010 for Chlordiazepoxide Hydrochloride Capsule

작성: PharmaCountry 팀

FDA granted approval (status AP) for VANGARD's ANDA088010 covering a 10 mg oral capsule of chlordiazepoxide hydrochloride, listed as discontinued.

The U.S. Food and Drug Administration (FDA) has issued an approval (status AP) for an Abbreviated New Drug Application (ANDA) numbered ANDA088010. The application, submitted by VANGARD, covers an oral capsule dosage form of chlordiazepoxide hydrochloride 10 mg (product number 001). The product is marked as discontinued and is not a reference drug. The original submission (type ORIG) was filed on March 28, 1983.

PharmaCountry 팀이 정리했습니다 · 출처: FDA.gov

주제:#ANDA #FDA #chlordiazepoxide #oral capsule #generic drug #regulatory